Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-02-03
1988-09-06
Rizzo, Nicholas S.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544266, 544267, C07D47304, A61K 3152
Patent
active
047693770
ABSTRACT:
Novel 8-phenylxanthines which are potent adenosine receptor antagonists.
REFERENCES:
patent: 3493573 (1970-02-01), Joullie et al.
patent: 4452788 (1984-06-01), Bristol et al.
patent: 4593095 (1986-06-01), Snyder et al.
patent: 4612315 (1986-09-01), Jacobsen et al.
Biochemical Pharmacology; vol. 30, 1981, pp. 325-333, Pergamon Press Ltd., Londres, GB; R. F. Bruns.
Life Sciences, vol. 31, No. 25, 1982, pp. 2857-2867, Pergamon Press Ltd., Washington, D.C., U.S.; P. H. Wu et al.
Life Sciences, vol. 24, No. 26, 1979, pp. 2475-2482, Pergamon Press Ltd., _Washington, D.C., U.S.; F. W. Smellie et al.
Chemical Abstracts, vol. 97, 1982, p. 88, No. 85177p, Columbus, Ohio, U.S.; J. P. Boulenger et al.
Chemical Abstracts, vol. 97, 1982, No. 156508k, Columbus, Ohio, U.S.; B. B. Fredholm et al.
Proceedings of the National Academy of Science U.S.A., vol. 80, Apr. 1983, pp. 2077-2080, Washington, U.S.; R. F. Bruns et al.
Bruns Robert F.
Daly John W.
Snyder Solomon H.
Rizzo Nicholas S.
The Johns Hopkins University
LandOfFree
Adenosine receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Adenosine receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adenosine receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1607033